Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Rutgers study identifies key protein for brain stem cell longevity

A receptor that was first identified as necessary for insulin action, that also is located on the neural stem cells found deep in the brains of mice, is pivotal for brain stem cell longevity, according to a Rutgers study, a finding that has important implications for brain health and future therapies for brain disorders.

11 May 2022

Cells do a little cleanup before mitosis

MIT researchers have discovered that before cells start to divide, they do a little cleanup, tossing out molecules that they appear not to need anymore.

10 May 2022

Complimentary tests to quantify cognitive changes in dogs could aid humans with Alzheimer's disease

Researchers have found that a suite of complimentary tests can quantify changes in dogs suspected of suffering from cognitive decline.

9 May 2022

Celebrating contributions to Alzheimer’s research and clinical care

The Mesulam Center for Cognitive Neurology and Alzheimer's Disease held the 28th annual Alzheimer Day on May 5, returning to campus for the first time in three years.

9 May 2022

Newly-discovered mechanism may help prevent the build-up toxic proteins in dementia

It's often said that a little stress can be good for you. Now scientists have shown that the same may be true for cells, uncovering a newly-discovered mechanism that might help prevent the build-up of tangles of proteins commonly seen in dementia.

6 May 2022

Study finds promising new treatment for patients with behavioral variant frontotemporal dementia

A Monash University led study has found a promising new treatment for patients with behavioural variant frontotemporal dementia, the second most common form of dementia in the under 60s – resulting in a stabilising of what would normally be escalating behavioural issues, and a slowing of brain shrinkage due to the disease.

6 May 2022

Influenza and pneumonia vaccinations linked with reduced risk of Alzheimer’s disease

Flu (influenza) and pneumonia vaccinations are associated with reduced risk of Alzheimer’s disease, according to new research reported at the Alzheimer’s Association International Conference 2020.

5 May 2022

Understanding the long-term impact of pandemic on Alzheimer’s research trials and people with dementia

COVID-19 and the global pandemic have caused significant disruption to all aspects of life including Alzheimer’s clinical research worldwide.

5 May 2022

Hearing and vision impairment found to be independently associated with cognitive decline

A new nationally representative study published online in the Journal of Alzheimer's Disease Reports found hearing impairment and vision impairment to be independently associated with cognitive impairment.

5 May 2022

Hypertonic saline solution enhances glymphatic spinal cord delivery of pharmaceutical agents

The glymphatic system enables the flow of cerebrospinal fluid to the brain tissue, particularly during sleep, enabling the fluid to cleanse the tissue and carry accumulated metabolites with it towards the bloodstream during waking hours.

4 May 2022

People with highest levels of antioxidants less likely to develop dementia, finds study

People with higher levels of antioxidants in their blood may be less likely to develop dementia, according to a study published in the May 4, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

4 May 2022

Elevated levels of PHGDH enzyme associated with Alzheimer’s disease pathology

Elevated levels of an enzyme called PHGDH in the blood of older adults could be an early warning sign of Alzheimer's disease, and a study led by the University of California San Diego provides new evidence to support this claim.

4 May 2022

Scientists discover a potential new method of active immunization to prevent Alzheimer's disease

During experiments in animal models, researchers at the University of Kansas have discovered a possible new approach to immunization against Alzheimer's disease (AD).

4 May 2022

Brain folds formed during fetal development could affect age at onset in frontotemporal dementia

Frontotemporal dementia begins relatively early compared to other forms of dementia. We still know relatively little about what causes the disease, however, new research from Lund University in Sweden shows that the folds in the brain that are formed in the latter stages of pregnancy could have an impact on the age at which the disease takes hold.

3 May 2022

Alzheimer's Disease News and Research

Further Reading

Rutgers study identifies key protein for brain stem cell longevity

Cells do a little cleanup before mitosis

Complimentary tests to quantify cognitive changes in dogs could aid humans with Alzheimer's disease

Celebrating contributions to Alzheimer’s research and clinical care

Newly-discovered mechanism may help prevent the build-up toxic proteins in dementia

Study finds promising new treatment for patients with behavioral variant frontotemporal dementia

Influenza and pneumonia vaccinations linked with reduced risk of Alzheimer’s disease

Understanding the long-term impact of pandemic on Alzheimer’s research trials and people with dementia

Hearing and vision impairment found to be independently associated with cognitive decline

Hypertonic saline solution enhances glymphatic spinal cord delivery of pharmaceutical agents

People with highest levels of antioxidants less likely to develop dementia, finds study

Elevated levels of PHGDH enzyme associated with Alzheimer’s disease pathology

Scientists discover a potential new method of active immunization to prevent Alzheimer's disease

Brain folds formed during fetal development could affect age at onset in frontotemporal dementia

Research shows how Alzheimer's disease affects the functional architecture of the brain

Study explores sex-driven differences in individualized clinical management of Alzheimer’s disease risk

Gum Health Day 2022 calls for prevention, early detection, and effective treatment of gum diseases

New insights into how NANOG protein facilitates the activation of human cell pluripotency

Tufts scientists discover a previously unknown function performed by astrocytes

Researchers unravel why neuropsychiatric symptoms appear in Alzheimer's patients before memory loss

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News